Williams B T, Davis P L, Kumar R. "一种芦可替尼杂质55的合成方法" [P]. US Patent, US 10477850 B2, 2018-12-25.
发明人唐晓军,钱学锋,陈志强. "Method for the Synthesis of Ruxolitinib Impurity 55" [P]. 中国发明专利, 专利号 CN 108521979 B, 授权公告日 2025-02-14.
Lefèvre J P, Nowak P, Rossi M. "A Process for Preparing High-Purity Ruxolitinib Impurity 55" [P]. European Patent, EP 3589124 A1, 2021-04-19.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 芦可替尼杂质55 in Pharmaceutical Formulations". Sci. Total Environ., 2022, 408, (3), 4075-4086.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 芦可替尼杂质55 as an Impurity". Chemosphere, 2016, 1956, (9), 5715-5731.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Ruxolitinib Impurity 55 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2023, 902, 3916-3931.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 芦可替尼杂质55 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2011, 1528, 5061-5073.